Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV002675827 | SCV002987368 | pathogenic | Adenylosuccinate lyase deficiency | 2023-07-26 | criteria provided, single submitter | clinical testing | For these reasons, this variant has been classified as Pathogenic. ClinVar contains an entry for this variant (Variation ID: 1942226). This variant has not been reported in the literature in individuals affected with ADSL-related conditions. This variant is present in population databases (rs774729848, gnomAD 0.0009%). This sequence change creates a premature translational stop signal (p.Arg270Thrfs*14) in the ADSL gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in ADSL are known to be pathogenic (PMID: 10888601, 20177786). |
Gene |
RCV005254122 | SCV005906462 | pathogenic | not provided | 2024-10-02 | criteria provided, single submitter | clinical testing | Frameshift variant predicted to result in protein truncation or nonsense mediated decay in a gene for which loss-of-function is a known mechanism of disease; Not observed at a significant frequency in large population cohorts (gnomAD); Has not been previously reported as pathogenic or benign in association with ADSL-related disorders to our knowledge; This variant is associated with the following publications: (PMID: 28127531) |